Tofacitinib
Tablet that blocks inflammation signals for arthritis and colitis.
- Starts working
- Varies
- Half-life
- About 3 hours
- In use since
- 2012
- Pregnancy
- Usually avoided
Overview
Tofacitinib is an oral JAK inhibitor for rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. A 2021 safety study found higher risks of heart events, cancer and clots than with TNF inhibitors in older people with risk factors, so its use is now more restricted.
How it works
Blocks the relay inside immune cells that passes on inflammation signals.
Tofacitinib belongs to the JAK inhibitors. How JAK inhibitors work: block JAK enzymes that pass messages from several inflammation signals into immune cells.
Uses
- Rheumatoid arthritis
- Psoriatic arthritis
- Ulcerative colitis
- Ankylosing spondylitis
Available as: tablet, modified-release tablet, oral solution.
Typical dose
- Adults
- 5 mg twice a day (10 mg twice a day for induction in ulcerative colitis).
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Cold-like infections
- Headache
- Diarrhoea
- Raised cholesterol
Serious — get medical help
Uncommon, but need prompt attention
- Shingles
- Blood clots
- Heart attacks and cancer in at-risk groups
- Serious infections
Warnings
- Avoided over 65, in smokers and with heart or clot risk unless no alternative
- Shingles vaccination advised
Interactions
- Strong CYP3A4 inhibitors — halve dose
- Rifampicin — ineffective
Other medicines in the atlas that need care with Tofacitinib, grouped by the reason:
Reduced effectModerateWith Carbamazepine, Efavirenz, Enzalutamide, Griseofulvin, Modafinil and 5 more
Enzyme induction lowers levels of this medicine, which may stop it working.
What's usually done: Monitor effect; dose changes or alternatives may be needed. The effect lasts weeks after stopping the inducer.
Raised drug levelsModerateWith Clarithromycin, Darunavir, Erythromycin, Itraconazole, Lopinavir-ritonavir and 2 more
Blocking CYP3A4 increases levels of this medicine, so side effects become more likely.
What's usually done: A dose reduction, alternative or extra monitoring may be needed.
Pregnancy and breastfeeding
Usually avoided
Not recommended.
Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.
Brand names
- United States
- Xeljanz
- United Kingdom
- Xeljanz
- India
- Tofacinix, Xeljanz
- Australia
- Xeljanz
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
History
2021
ORAL Surveillance trial leads to boxed warnings across JAK inhibitors.
Common questions
Is a tablet better than an injection?
It's more convenient, but the safety profile means it's chosen carefully.
Do I need a prescription for Tofacitinib?
Yes — Tofacitinib is prescription-only in most countries.
Can I take Tofacitinib during pregnancy?
Usually avoided. Not recommended. Always check with a doctor or midwife.
Related medicines
Adalimumab
Biologic injection for arthritis, IBD and psoriasis.
RxTNF inhibitorsMethotrexate
Once-weekly anchor drug for rheumatoid arthritis.
RxWHOConventional DMARDsInfliximab
IV anti-TNF biologic for Crohn's and arthritis.
RxTNF inhibitorsBaricitinib
Oral JAK inhibitor for rheumatoid arthritis, eczema and alopecia areata.
RxJAK inhibitorsUpadacitinib
Selective JAK1 inhibitor for arthritis, eczema and inflammatory bowel disease.
RxJAK inhibitors
Sources and official information
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.